By API User
LUXEMBOURG / ACCESSWIRE / October 20, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023 ended June 30, 2023. The main highlights of the Company’s business update are as follows: … Continued
By API User
LUXEMBOURG / ACCESSWIRE / October 17, 2023 / Moolec Science SA (NASDAQ:MLEC; "Company"; "Moolec”), a science-based food ingredient company, announced today that it has entered into agreements to issue a convertible note due 2026 to Grupo Insud ("Insud") in a principal amount of approximately US $21 million (the "Insud Convertible Note") with a strike price … Continued
By API User
Researchers at Monash University have identified a new way of mapping ‘phosphenes’ – the visual perception of the bright flashes we see when no light is entering the eye – to improve the outcome of surgery for patients receiving a cortical visual prosthesis (‘bionic eye’). Cortical visual prostheses are devices implanted onto the brain … Continued
By API User
Highlights Selection of biomarkers panel for Cleo’s ovarian cancer test-kit has been finalised Antibody development has advanced increasing confidence for commercial assay development and upscaling for commercial manufacturing The Company is in final stages evaluating four commercial antibody manufacturing partners MELBOURNE, AUSTRALIA, 9 October, 2023: Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or … Continued
By API User
BUFFALO, NY / ACCESSWIRE / October 3, 2023 / ZeptoMetrix® is pleased to announce it has been awarded an IVDR Quality Management System certificate from British Standards Institution BSI, NB 2797, one of the notified bodies under the new EU In Vitro Diagnostics Regulation (IVDR). This certificate applies to the majority of the current portfolio … Continued
By API User
SAN FRANCISCO, CA and TAIPEI, TAIWAN / ACCESSWIRE / October 3, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of patients suffering from different solid tumors or hematological malignancies with significant unmet medical needs, today announced that the first patient … Continued
By API User
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with … Continued
By API User
BRISBANE, AU – 26-Sep-2023 Pure Souls Pet Aquacremation, Australia’s first carbon-neutral pet crematorium, is excited to announce its array of high-quality, environmentally-conscious services. Recognized as the top-rated pet aquacremation facility on Google, Pure Souls leverages the power of renewable energy to provide pet owners a sustainable, kind alternative to traditional pet cremation. Operating exclusively on … Continued
By API User
Melbourne, Australia and Irvine, CA USA, 5 September 2023 (AEST): INOVIQ Limited (ASX:IIQ) (INOVIQ), a developer of next-generation exosome solutions and precision diagnostics, and ResearchDx Inc (ResearchDx), a Contract Diagnostics Organization (CDO) offering complete in vitro diagnostic (IVD) services, today announced a license and supply agreement for INOVIQ’s EXO-NET® exosome capture technology to enable provision of exosome isolation, biomarker discovery and diagnostics development services in the USA. The ResearchDx partnership builds on the previously announced Joint Marketing Agreement for INOVIQ’s EXO-NET exosome capture technology and Promega Nucleic Acid purification systems (ASX: 6 July2023). EXO-NET license agreement to ResearchDx INOVIQ and ResearchDx have signed a license and supply agreement that will enable the companies todeliver EXO-NET enabled High-Throughput (HT) exosome isolation, biomarker discovery and diagnostics development services to customers in the USA. Establishment of EXO-NET services in the USA follows the recent introduction of INOVIQ’s EXO-NET services from its Australian laboratory (see below). This new agreement combines the expertise … Continued
By API User
SHANGHAI, CHINA and TAIPEI, TAIWAN / ACCESSWIRE / August 28, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech, Inc., a global biopharmaceutical company developing biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases, today announced that the two … Continued
